Main Article Content

Abstract

This scoping review aims to provide an overview of the existing literature on degenerative diseases occurring during pregnancy, focusing on their prevalence, clinical presentation, management, and impact on maternal and fetal health. Methods: A systematic search was conducted in electronic databases, including 11 relevant studies. These studies were analyzed to identify common degenerative diseases, their associated risk factors, diagnostic strategies, and available treatment options. Results: The scoping review revealed a broad spectrum of degenerative diseases encountered during pregnancy, including gestational diabetes, preeclampsia, and maternal hypertension, among others. These conditions often pose significant challenges to both maternal and fetal well-being. The review also highlighted the importance of early detection and comprehensive management strategies. Conclusion: Degenerative diseases in pregnancy are a complex and multifaceted issue that requires further research and awareness. This scoping review offers a comprehensive overview of the current state of knowledge in this area, serving as a valuable resource for healthcare professionals, researchers, and policymakers to address these challenges and improve the care of pregnant individuals with degenerative disease.

Keywords

Degenerative diseases, pregnancy, scoping review, maternal health, fetal health, management.

Article Details

References

  1. Baykus, Y., Yavuzkir, S., Ustebay, S., Ugur, K., Deniz, R., & Aydin, S. (2019). Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus. Peptides, 120, 170132. https://doi.org/10.1016/J.PEPTIDES.20
  2. 170132.
  3. Bjelica, A. et al. (2018) ‘The phenomenon of pregnancy
  4. - a psychological view.’, Ginekologia polska, 89(2),
  5. pp. 102–106. Available at: https://doi.org/10.5603/GP.a2018.001 7.
  6. Costas, T. and Gomes-Ferreira, M. (2023) Physiological and Hormonal Changes During Pregnancy, Book cover Post- maternity Body Changes. https://link.springer.com/chapter/10.1 007/978-3-030- 43840-1_2#citeas.
  7. Available at: https://doi.org/https://doi.org/10.100 7/978-3-030-43840-12.
  8. Friel, L.A. (2023) Overview of Disease During Pregnancy. Available at: https://www.msdmanuals.com/home/ women-s- health-issues/pregnancy-complicated-by disease/overview-of- disease-during-pregnancy.
  9. Hasija, A., Balyan, K., Debnath, E., V, R., & Kumar, M. (2021). Prediction of hypertension in pregnancy in high risk women using maternal factors and serial placental profile in second and third trimester. Placenta, 104, 236–242.
  10. https://doi.org/10.1016/J.PLACENTA.2 021.01.005
  11. Kivelä, J., Sormunen-Harju, H., Girchenko, P. V.,
  12. Huvinen, E., Stach-Lempinen, B., Kajantie, E., Villa,
  13. P. M., Reynolds, R. M., Hämäläinen, E. K., Lahti- Pulkkinen, M., Murtoniemi, K. K., Laivuori, H., Eriksson,
  14. J. G., Räikkönen, K., & Koivusalo, S. B. (2021). Longitudinal Metabolic Profiling of Maternal Obesity, Gestational Diabetes, and Hypertensive Pregnancy Disorders. The Journal of Clinical Endocrinology & Metabolism, 106(11),e4372– e4388. https://doi.org/10.1210/CLINEM/DGA B475
  15. Lai, J., Syngelaki, A., Nicolaides, K. H., von Dadelszen, P., & Magee, L. A. (2021). Impact of new definitions of preeclampsia at term on identification of adverse maternal andperinatal outcomes. American Journal of Obstetrics and Gynecology, 224(5),518.e1-518.e11. https://doi.org/10.1016/J.AJOG.2020.1 1.004
  16. Lewandowska, M., Więckowska, B., & Sajdak, S. (2020). Pre-Pregnancy Obesity, Excessive Gestational Weight Gain, and the Risk of Pregnancy-Induced Hypertension and Gestational Diabetes Mellitus. Journal of Clinical Medicine 2020, Vol. 9, Page 1980, 9(6), 1980.https://doi.org/10.3390/JCM9061980
  17. Magee, L. A., Singer, J., Lee, T., Rey, E., Asztalos, E., Hutton, E., Helewa, M., Logan, A. G., Ganzevoort, W., Welch, R., Thornton, J. G., Woo Kinshella, M. L., Green, M., Tsigas, E., & von Dadelszen, P. (2021). The impact of preeclampsia definitions on the identification of adverse outcome risk in hypertensive pregnancy – analyses from the CHIPS trial (Control of Hypertension in Pregnancy Study). BJOG: An International Journal of Obstetrics & Gynaecology, 128(8), 1373–1382. https://doi.org/10.1111/1471- 0528.16602.
  18. Muglia, L.J. et al. (2022) ‘Maternal factors during pregnancy influencing maternal, fetal, and childhood outcomes’, BMC Medicine, 20(1), pp. 1–5. Available at: https://doi.org/10.1186/s12916- 022- 02632-6.
  19. Nunes, J. S., Ladeiras, R., Machado, L., Coelho, D., Duarte, C., & Furtado, J. M. (2020). The Influence of Preeclampsia, Advanced Maternal Age and Maternal Obesity in Neonatal Outcomes Among Women with Gestational Diabetes. Revista Brasileira de Ginecologia e Obstetrícia, 42(10), 607–613.https://doi.org/10.1055/S-0040-1710300.
  20. Sari, M.H.N. et al. (2022) Penyakit dan Kelainan dari Kehamilan. Padang: PT. Global Eksekutif Teknologi. Available at: https://doi.org/10.36089/job.v14i2.62 3.
  21. Sriwahyuni and Nour Srinayahr (2023) Jenis Penyakit Degeneratif. Purbalingga: Eurika Media Aksara.
  22. Shah, N. S., Wang, M. C., Kandula, N. R., Carnethon, M.
  23. R., Gunderson, E. P., Grobman, W. A., & Khan, S.
  24. S. (2022). Gestational Diabetes and Hypertensive Disorders of Pregnancy by Maternal Birthplace. American Journal of Preventive Medicine, 62(4), e223–e231. https://doi.org/10.1016/J.AMEPRE.202 1.10.007.
  25. Sriwahyuni and Nour Srinayahr (2023) Jenis Penyakit Degeneratif. Purbalingga: Eurika Media Aksara.
  26. Tian, T., Wang, L., Ye, R., Liu, J., & Ren, A. (2020).
  27. Maternal hypertension, preeclampsia, and risk of neonatal respiratory disorders in a large prospective cohort study. Pregnancy Hypertension, 19, 131–137. https://doi.org/10.1016/J.PREGHY.202 0.01.006.
  28. Weimer, L.H. (2020) Neuromuscular disorders in pregnancy, Neurology and Pregnancy: Neuro- Obstetric Disorders. New York, NY: Elsevier BV Available at: https://doi.org/https://doi.org/10.101 6/B978-0-444-64240-0.00012-X.